KYKatsuhiko Yasuda

Katsuhiko Yasuda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katsuhiko Yasuda has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Hidetaka Okada

    Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Japan

    13 shared publications
  • Hideharu Kanzaki

    Department of Obstetrics and Gynecology Kansai Medical University Moriguchi Osaka Japan

    12 shared publications
  • Tatsuya Nakajima

    Department of Obstetrics and Gynecology, Affiliated Takii Hospital, Kansai Medical University, Japan

    7 shared publications
  • Genichiro Sumi

    Department of Obstetrics and Gynecology, Kansai Medical University, Moriguchi, Osaka, Japan

    5 shared publications
  • Hisayuu Cho

    Department of Obstetrics and Gynecology Kansai Medical University Moriguchi Osaka Japan

    5 shared publications
  • Tomoko Tsuzuki

    Department of Obstetrics and Gynecology Kansai Medical University Moriguchi Osaka Japan

    5 shared publications

Latest Publications

  • Open Access

    Monozygotic Twins with Ovarian Cancer Carrying a Pathogenic BRCA1 Germline Mutation: a Case Report

    by Takuya Yokoe, Katsuhiko Yasuda, Tomoo Yoshimura, Aoi Hattori, Tomomi Mizokami, Aya Yoshida, Chika Sato, Masato Kita, Hidetaka Okada

  • Open Access

    Ovarian hyperstimulation syndrome following surgical removal of a complete hydatidiform mole: a case report

    by Hiroaki Tsubokura, Yohei Ikoma, Takuya Yokoe, Tomoo Yoshimura, Katsuhiko Yasuda

    Background: Generally, ovarian hyperstimulation syndrome develops after superovulation caused by ovulation-inducing drugs in infertile patients. However, ovarian hyperstimulation syndrome associated with natural pregnancy is rare, and most cases of ovarian hyperstimulation syndrome have been associated with a hydatidiform mole. Case presentation: We describe a case of a 16-year-old Japanese girl with a complete hydatidiform mole. The patient was referred for intensive examination and treatment of the hydatidiform mole and underwent surgical removal of the hydatidiform mole at 9 weeks, 5 days of gestation. Histopathological examination revealed a complete hydatidiform mole. The patient’s blood human chorionic gonadotropin level decreased from 980,823 IU/L to 44,815 IU/L on postoperative day 4, and it was below the cutoff level on postoperative day 64. Transvaginal ultrasonography on postoperative day 7 revealed a multilocular cyst measuring 82 × 43 mm in the right ovary and a multilocular cyst measuring 66 × 50 mm in the left ovary. Both ovarian cysts enlarged further. Magnetic resonance imaging on postoperative day 24 revealed that the right multilocular ovarian cyst had enlarged to 10 × 12 cm and that the left multilocular ovarian cyst had enlarged to 25 × 11 cm. Blood examination showed an elevated estradiol level as high as 3482 pg/ml. We diagnosed the patient with bilateral giant multilocular cysts accompanied by ovarian hyperstimulation syndrome because of the rapid increase in the size of the cysts. The patient complained of mild abdominal bloating; however, symptoms such as nausea, vomiting, dyspnea, and abdominal pain were not observed. Therefore, we chose spontaneous observation in the outpatient clinic. The cysts gradually decreased and disappeared on postoperative day 242. Conclusion: Physicians should be aware that ovarian cysts can occur and can increase rapidly after abortion of a hydatidiform mole. However, the ovarian cyst can return to its original size spontaneously even if it becomes huge.


  • The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone/progesterone receptor pathway

    by Katsuhiko Yasuda, Gen-Ichiro Sumi, Hiromi Murata, Naoko Kida, Takeharu Kido, Hidetaka Okada


  • Open Access

    Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report

    by Katsuhiko Yasuda, Tomoo Yoshimura, Hiroaki Kitade, Hidesuke Yanagida, Naoki Hosaka

    In general, splenic metastasis of epithelial ovarian cancer is considered a terminal stage resulting in widespread metastasis. Solitary splenic metastasis of epithelial ovarian cancer is rare in patients with post-treatment ovarian cancer with long disease-free intervals. We report a case of a 62-year-old Japanese woman who presented with elevated serum cancer antigen 125 due to a solitary splenic metastasis of ovarian cancer. She underwent primary open cytoreduction including resection of the right ovarian cancer and postoperative chemotherapy, followed by secondary open cytoreduction and additional postoperative chemotherapy. The disease-free interval was more than 5 years after the additional postoperative chemotherapy. She did not complain of any symptoms and there were no abnormal findings except for elevated cancer antigen 125. However, computed tomography and magnetic resonance imaging revealed a tumor of 6.5 × 4.5 cm in her spleen, and 18F-fluorodeoxyglucose positron emission tomography-computed tomography showed no other metastatic lesions. Laparoscopic splenectomy was performed as tertiary cytoreduction with a diagnosis of a solitary splenic metastasis. Her elevated cancer antigen 125 immediately decreased to within the normal range after the splenectomy. On microscopic examination, the tumor was grade 3 endometrioid adenocarcinoma localized in the spleen, consistent with the previous grade 3 endometrioid adenocarcinoma ovarian cancer. Elevated cancer antigen 125 is useful for early detection of metastasis of ovarian cancer. Computed tomography, magnetic resonance imaging, and 18F-fluorodeoxyglucose positron emission tomography-computed tomography are useful to evaluate whether splenic metastasis of ovarian cancer is solitary, and laparoscopic splenectomy is safe and feasible for a solitary splenic metastasis.


  • Late pubertal growth spurt in a girl with growth hormone deficiency: Is Kaufmann therapy effective in a girl with short stature who responds poorly to growth hormone therapy and estrogen‐replacement therapy?

    by Katsuhiko Yasuda

    A Japanese senior high school girl aged 18 years and 5 months with growth hormone deficiency was referred for primary amenorrhea. Her height was 1.36 m, and her bodyweight was 23.5 kg. She had received daily growth hormone therapy from the age of 5 years. Growth hormone therapy was discontinued at the age of 16 years and 11 months, and estrogen-replacement therapy (ERT) was started to stimulate secondary sexual characteristics. Although ERT was performed until the age of 18 years and 11 months, genital bleeding did not occur. ERT was changed to Kaufmann therapy, and the first genital bleeding occurred 1 year and 4 months later. Finally, regular medically induced menses occurred at the age of 21 years and 10 months. Her height increased by 9 cm in 1 year after the initiation of menstrual bleeding. Kaufmann therapy was associated not only with menstrual bleeding but also with growth spurt.


  • Lipid‐soluble fraction of Shakuyaku‐kanzo‐to inhibits myometrial contraction in pregnant women

    by Genichiro Sumi, Katsuhiko Yasuda, Shoko Tsuji, Chiharu Kanamori, Tomoko Tsuzuki, Hisayuu Cho, Akemi Nishigaki, Hidetaka Okada, Hideharu Kanzaki

    Aim: Shakuyaku‐kanzo‐to, a Kampo medicine composed equally of shakuyaku and kanzo, is an antispasmodic drug that can inhibit contraction of uterine smooth muscles in pregnant women and rats. We aimed to test the inhibitory effects of water‐ and lipid‐soluble extracts of shakuyaku‐kanzo‐to, shakuyaku, and kanzo in order to identify the fraction responsible for inhibiting uterine smooth muscle contraction in pregnancy.Material and Methods: Myometrial tissues were obtained from pregnant women and rats. The water‐ and lipid‐soluble fractions of shakuyaku‐kanzo‐to, shakuyaku, and kanzo were obtained using the method of Bligh and Dyer. Lipid‐soluble fractions were also partially purified using thin‐layer chromatography (TLC) with a chloroform : methanol : water (65:25:4 by volume) solvent system to yield four TLC fractions. The effect of each fraction on oxytocin‐induced myometrial contraction was examined in vitro.Results: Lipid‐soluble fractions obtained from shakuyaku‐kanzo‐to and kanzo inhibited myometrial contraction; water‐soluble fractions had no effect. Of the four TLC fractions, the inhibitory effect was greatest with TLC fraction 1 (0.75 < Rf value ≤ 1.0). Neither the water‐soluble nor the lipid‐soluble fraction from shakuyaku inhibited myometrial contraction.Conclusions: These results suggest that lipid‐soluble substances with low polarity derived from kanzo are responsible for the inhibitory effect of shakuyaku‐kanzo‐to on myometrial contraction.


  • Effects of ovarian hormone treatment on the gene expression of muscarinic acetylcholine receptors in the ovariectomized rat myometrium

    by Katsuhiko Yasuda, Genichiro Sumi, Chiharu Kanamori, Tatsuya Nakajima, Tomoko Tsuzuki, Hisayuu Cho, Akemi Nishigaki, Hidetaka Okada, Hideharu Kanzaki


  • Two-step inhibitory effect of kanzo on oxytocin-induced and prostaglandin F2α-induced uterine myometrial contractions

    by Genichiro Sumi, Katsuhiko Yasuda, Chiharu Kanamori, Megumi Kajimoto, Akemi Nishigaki, Tomoko Tsuzuki, Hisayuu Cho, Hidetaka Okada, Hideharu Kanzaki

    We previously reported that shakuyaku-kanzo-to, a kampo medicine consisting of shakuyaku and kanzo, has an inhibitory effect on myometrial contractions in pregnant women. In this study, we evaluated the effects of kanzo, glycyrrhizin (a major component of kanzo), glycyrrhetinic acid (GA; a major metabolite of glycyrrhizin), shakuyaku, and paeoniflorin (a major component of shakuyaku) on agonist-induced contractions of the uterus of pregnant humans and rats. We prepared myometrial strips from the uterus of pregnant humans and rats and induced contractions with oxytocin (50 μU/mL) or prostaglandin F2α (PGF2α) (10−7 or 10−6 M). Kanzo (250 μg/mL) and GA (5 × 10−6 M) inhibited the oxytocin-induced and PGF2α-induced contractions in pregnant human and rat myometrium, but shakuyaku (250 μg/mL), paeoniflorin (10−5 M), and glycyrrhizin (10−5 M) did not inhibit contractions in either. Interestingly, kanzo and GA showed an inhibitory effect after temporarily enhancing the PGF2α-induced contractions in the rat myometrium, but not in the human myometrium. These results suggest that kanzo has at least a two-step inhibitory effect on the myometrial contractions that originate from the kanzo itself and a metabolite of glycyrrhizin in kanzo. Furthermore, kanzo was found to be safe for inhibiting PGF2α-induced contractions in humans because it did not temporarily enhance PGF2α-induced contractions.


  • The concentration of human follicular fluid stromal cell-derived factor-1 is correlated with luteinization in follicles

    by Akemi Nishigaki, Hidetaka Okada, Rika Okamoto, Kayo Shimoi, Hiroe Miyashiro, Katsuhiko Yasuda, Hideharu Kanzaki

    Stromal cell-derived factor-1 (SDF-1/CXCL12) and vascular endothelial growth factor (VEGF) are angiogenic factors that have possible roles in ovarian function. The objectives of this study were to investigate the association between the individual concentrations of SDF-1 and VEGF and sex steroid hormones in human preovulatory follicles and to verify the SDF-1 expression in ovarian follicles. Follicular fluid (FF) and luteinizing granulosa cells (LGCs) were collected from follicles at the time of oocyte retrieval. The concentrations of SDF-1, VEGF, estradiol (E2) and progesterone (P4) were determined by biochemical assay. The expression levels of SDF-1 mRNA and protein were analyzed by RT-PCR and immunohistochemical analysis, respectively. A total of 177 follicles were analyzed. The FF concentrations of SDF-1 and VEGF positively correlated with P4 concentrations (r = 0.457 and p < 0.01, r = 0.698 and p < 0.01, respectively), but did not correlate with E2 concentrations in FF. Furthermore, we confirmed that SDF-1 mRNA was expressed in LGCs and SDF-1 protein is present in the granulosa cells of the human ovary. Our findings suggest that SDF-1, as well as VEGF, may play important modulatory roles in early luteinization of human preovulatory follicles.